Expand CLRB Menu
CLRB MENU

CLRB Stock Posts


CLRB #CellectarBiosciences stock declines -17.3% in premarket,

Premarket Decliner

CLRB Cellectar Biosciences6.17+0.39+6.8%

Premarket:5.10-1.07 (-17.3%)

Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million

Globe NewswireTue, 7-Oct 8:30 AM
CLRB #CellectarBiosciences stock declines -26.6% in premarket,

Premarket Decliner

CLRB Cellectar Biosciences7.11-0.79-10.0%

Premarket:5.22-1.89 (-26.6%)

Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering

Globe NewswireTue, 1-Jul 9:25 AM
Unusual Option Volume

CLRB Cellectar Biosciences0.58+0.30 (+108.6%)

Cellectar Biosciences trades 3,206 contracts. The company has the following event: on Jun 4, 2025. News: Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM)
View Details...
$CLRB Earnings November 18 BMO. 20-Dec-24 Straddle Implies ±24.8% Move vs Prev. Move +8.6%
CLRB #CellectarBiosciences stock declines -16.6% in premarket,

Premarket Decliner

CLRB Cellectar Biosciences3.02+0.50+19.8%

Premarket:2.52-0.50 (-16.6%)

Cellectar Biosciences' Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom's Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 Months

Globe NewswireTue, 23-Jul 6:40 AM
CLRB #CellectarBiosciences stock declines -31.4% in premarket,

Premarket Decliner

CLRB Cellectar Biosciences2.77+0.11+4.1%

Premarket:1.90-0.87 (-31.4%)

Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement

Globe NewswireWed, 23-Dec 8:38 AM
Load Earlier Posts
Market Data Delayed 15 Minutes